Short answer
Centene Corporation (CNC) filed its Q1 2025 10-Q quarterly report on Apr 25, 2025 for the quarter ended Mar 31, 2025. Quarterly revenue was $42.5B (up 16.9% year over year) with net income of $1.3B.
Q1 2025 key financials · XBRL
- Revenue
- $42.5B
- +16.9% YoY
- Net income
- $1.3B
- +12.7% YoY
- Operating margin
- 3.6%
- Gross margin
- 12.4%
- EPS (diluted)
- $2.63
- +21.8% YoY
Source: XBRL data from the Centene Corporation (CNC) Q1 2025 10-Q on SEC EDGAR. USD.
Centene Corporation Q1 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New risk from U.S. government tariffs and retaliatory tariffs impacting costs of drugs, devices, and supplies with uncertain amount and duration
- Updated financial risk: revenue timing mismatch with tariff-driven cost increases due to annual pricing of government-sponsored health programs
- Compliance risk from inability to adjust premiums timely against rising healthcare costs caused by tariffs, affecting results and cash flows
- Operational risk: specialty pharmacy supply disruptions from tariffs could delay prescription processing, impacting near-term results
- No liquidity, debt maturity, or currency exposure changes disclosed in this quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Centene Corporation quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.